2Fromowitz FB,Viola MV,Chao S,et al.Ras p21 expression in the prograssi of breast cancer.Hum Pathol,1987,18:1268-1275. 被引量：1
3McLaren J,Taylor DJ,Bell SC.Increased concentration of pro-matrix metalloproteinase 9 in term fetal membranes overlying the cervix before labor implications for membrane remodeling and rupture.Am J Obstet Gynecol,2000,182:409-416. 被引量：2
4Uchide K,Ueno H,Inoue M,et al.Matrix metalloproteinase-9 and tensile strength of fetal membranes in uncomplicated labor.Obstet Gynecol,2000,95:851-855. 被引量：1
5Vadillo-Ortega F,Hernandez A,Gonzalez-Avila G,et al.Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes.Am J Obstet Gynec 被引量：1
6Athayde N,Samuel SE,Roberto R,et al.A role for matrixmetalloproteinase-9 in spontaneous rupture of the fetal membranes.Am J obstet Gynecal,1998,179:1248-1253. 被引量：2
7Fortunato SJ,Menon R,Lombardi SJ.MMP/TIMP imbalance in amniotic fluid during PROM:an indirect support for endogenous pathway to membrane rupture.Jperinat Med,1999,27(5):362-368. 被引量：1
8Maymon E,Romero R,pacora P,et al.Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in parturition,spontaneous rupture of membranes and intra-amniotic infection.Am J Obstet Gynecol,2000,183:887-894. 被引量：1
9Soeda Y.A study on tissue inhibitor of metalloproteinases (TIMP) during pregnancy and at delivery.[Japanese] Nippon Sanka Fujinka Gakkai Zasshi ,1993;45(4):340-346. 被引量：1
